Biology Dedman College of Humanities and Sciences Dedman College Research Faculty News

New Research Study Points to Potential of Oleandrin as Therapeutic Strategy for Treatment of HTLV-1, Which Affects Between 10 Million to 15 Million Worldwide


Originally Posted: October 29, 2019

A 2019 research publication from Robert Harrod (Department of Biological Sciences) was cited onĀ Businesswire. This work was the product of a collaboration with investigators at the UT-Houston M.D. Anderson Cancer Center. The paper was published in the Journal of Antivirals & Antiretrovirals:

Hutchison T., Yapindi L., Malu A., Newman R.A., Sastry K.J., & Harrod R (2019). The botanical glycoside oleandrin inhibits human T-cell leukemia virus type-1 infectivity and Env-dependent virological synapse formation. J. Antivirals & Antiretrovirals 11(2), 1-11.